154 related articles for article (PubMed ID: 11944604)
1. Insulin glargine: a new long-acting insulin product.
Reinhart L; Panning CA
Am J Health Syst Pharm; 2002 Apr; 59(7):643-9. PubMed ID: 11944604
[TBL] [Abstract][Full Text] [Related]
2. Insulin glargine.
Campbell RK; White JR; Levien T; Baker D
Clin Ther; 2001 Dec; 23(12):1938-57; discussion 1923. PubMed ID: 11813930
[TBL] [Abstract][Full Text] [Related]
3. Insulin glargine: a systematic review of a long-acting insulin analogue.
Wang F; Carabino JM; Vergara CM
Clin Ther; 2003 Jun; 25(6):1541-77, discussion 1539-40. PubMed ID: 12860485
[TBL] [Abstract][Full Text] [Related]
4. Insulin glargine: a review of its therapeutic use as a long-acting agent for the management of type 1 and 2 diabetes mellitus.
McKeage K; Goa KL
Drugs; 2001; 61(11):1599-624. PubMed ID: 11577797
[TBL] [Abstract][Full Text] [Related]
5. Insulin glargine: a new basal insulin.
Levien TL; Baker DE; White JR; Campbell RK
Ann Pharmacother; 2002 Jun; 36(6):1019-27. PubMed ID: 12022906
[TBL] [Abstract][Full Text] [Related]
6. Spotlight on insulin glargine in type 1 and 2 diabetes mellitus.
McKeage K; Goa KL
Treat Endocrinol; 2002; 1(1):55-8. PubMed ID: 15765621
[TBL] [Abstract][Full Text] [Related]
7. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.
Ratner RE; Hirsch IB; Neifing JL; Garg SK; Mecca TE; Wilson CA
Diabetes Care; 2000 May; 23(5):639-43. PubMed ID: 10834423
[TBL] [Abstract][Full Text] [Related]
8. A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.
Raskin P; Klaff L; Bergenstal R; Hallé JP; Donley D; Mecca T
Diabetes Care; 2000 Nov; 23(11):1666-71. PubMed ID: 11092290
[TBL] [Abstract][Full Text] [Related]
9. Comparison of insulin glargine and NPH insulin in the treatment of type 2 diabetes: a review of clinical studies.
Duckworth W; Davis SN
J Diabetes Complications; 2007; 21(3):196-204. PubMed ID: 17493554
[TBL] [Abstract][Full Text] [Related]
10. Insulin glargine: a new once-daily basal insulin for the management of type 1 and type 2 diabetes mellitus.
Lam S
Heart Dis; 2003; 5(3):231-40. PubMed ID: 12783637
[TBL] [Abstract][Full Text] [Related]
11. Insulin glargine: an updated review of its use in the management of diabetes mellitus.
Dunn CJ; Plosker GL; Keating GM; McKeage K; Scott LJ
Drugs; 2003; 63(16):1743-78. PubMed ID: 12904090
[TBL] [Abstract][Full Text] [Related]
12. [Comparison between basal insulin glargine and NPH insulin in patients with diabetes type 1 on conventional intensive insulin therapy].
Pesić M; Zivić S; Radenković S; Velojić M; Dimić D; Antić S
Vojnosanit Pregl; 2007 Apr; 64(4):247-52. PubMed ID: 17580534
[TBL] [Abstract][Full Text] [Related]
13. Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.
Rosenstock J; Dailey G; Massi-Benedetti M; Fritsche A; Lin Z; Salzman A
Diabetes Care; 2005 Apr; 28(4):950-5. PubMed ID: 15793205
[TBL] [Abstract][Full Text] [Related]
14. Comparison of once-daily glargine insulin with twice-daily NPH/regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery.
Yeldandi RR; Lurie A; Baldwin D
Diabetes Technol Ther; 2006 Dec; 8(6):609-16. PubMed ID: 17109592
[TBL] [Abstract][Full Text] [Related]
15. Nocturnal glucose metabolism after bedtime injection of insulin glargine or neutral protamine hagedorn insulin in patients with type 2 diabetes.
Linn T; Fischer B; Soydan N; Eckhard M; Ehl J; Kunz C; Bretzel RG
J Clin Endocrinol Metab; 2008 Oct; 93(10):3839-46. PubMed ID: 18611975
[TBL] [Abstract][Full Text] [Related]
16. A comparison of bedtime insulin glargine with bedtime neutral protamine hagedorn insulin in patients with type 2 diabetes: subgroup analysis of patients taking once-daily insulin in a multicenter, randomized, parallel group study.
Fonseca V; Bell DS; Berger S; Thomson S; Mecca TE
Am J Med Sci; 2004 Nov; 328(5):274-80. PubMed ID: 15545844
[TBL] [Abstract][Full Text] [Related]
17. Insulin glargine versus NPH insulin in patients with type 1 diabetes.
Ratner R
Drugs Today (Barc); 2003 Nov; 39(11):867-76. PubMed ID: 14702132
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial comparing the rate of hypoglycemia--assessed using continuous glucose monitoring--in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study).
Danne T; Philotheou A; Goldman D; Guo X; Ping L; Cali A; Johnston P
Pediatr Diabetes; 2013 Dec; 14(8):593-601. PubMed ID: 23730996
[TBL] [Abstract][Full Text] [Related]
19. Insulin glargine.
Gillies PS; Figgitt DP; Lamb HM
Drugs; 2000 Feb; 59(2):253-60; discussion 261-2. PubMed ID: 10730548
[TBL] [Abstract][Full Text] [Related]
20. Insulin therapy in type 2 diabetes: role of the long-acting insulin glargine analogue.
Yki-Järvinen H
Eur J Clin Invest; 2004 Jun; 34(6):410-6. PubMed ID: 15200492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
